Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,695.00    -90.00 (-1.33%)
Bid:
6,690.00
Ask:
6,700.00
Spread: 10.00 (0.149%)
Market Cap: £4.94b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Holding(s) in Company

20 Feb 2006 11:03

Spirax-Sarco Engineering PLC20 February 2006 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Name of company SPIRAX-SARCO ENGINEERING PLC 2. Name of shareholder having a major interest ARNHOLD AND S. BLEICHROEDER ADVISORS, LLC 3. Please state whether notification indicates that it is in respect of holdingof the shareholder named in 2 above or in respect of a non-beneficial interestor in the case of an individual holder if it is a holding of that person'sspouse or children under the age of 18 IN RESPECT OF CLIENTS WHOSE PORTFOLIOS ARE MANAGED BY THE SHAREHOLDERS NAMED IN BOX 2 ABOVE 4. Name of the registered holder(s) and, if more than one holder, the number ofshares held by each of them SEE BELOW 5. Number of shares / amount of stock acquired NOT STATED 6. Percentage of issued class NOT STATED 7. Number of shares / amount of stock disposed NOT STATED 8. Percentage of issued class NOT STATED 9. Class of security ORDINARY 10. Date of transaction 14.2.06 11. Date company informed 16.2.06 12. Total holding following this notification 4,607,325 13. Total percentage holding of issued class following this notification 5.98% (SHARE CAPITAL 76,987,407) 14. Any additional information 15. Name of contact and telephone number for queries FAY RICKETTS, TEL. 01242 521361 16. Name and signature of authorised company official responsible for makingthis notification FAY RICKETTS Date of notification 20.2.06 The FSA does not give any express or implied warranty as to the accuracy of thisdocument or material and does not accept any liability for error or omission.The FSA is not liable for any damages (including, without limitation, damagesfor loss of business or loss of profits) arising in contract, tort or otherwisefrom the use of or inability to use this document, or any material contained init, or from any action or decision taken as a result of using this document orany such material. Letter to Spirax-Sarco Engineering plc dated February 15, 2006 Mr Smith Amended Disclosure of Substantial Shareholdings Under the Companies Act of 1985 As of February 14, 2006 Arnhold and S. Bleichroeder Advisers, LLC ("ASBA") held,in the aggregate, a total of 4,607,325 shares of Spirax-Sarco Engineering, Plc.Those shares represent 5.99% of the 76,923,407 outstanding shares of thecompany. The registered holders of the shares managed by ASBA on February 14, 2006 aregiven below. Arnhold and S. Bleichroeder Diversified International Equity Fund 200,910City of Hartford Municipal Employees' Retirement Fund 14,718Ewing Marion Kauffman Foundation 39,865First Eagle Overseas Fund 4,061,330First Eagle Overseas Variable Fund 89,600Genesee County Employees' Retirement System 25,000MacArthur Foundation Trust 412Raytheon Pension Fund 54,970Schlumberger Limited 47,320Utah Retirement Systems 19,720United Food and Commercial Workers' Union 53,480 I request that you make the information disclosed in this notice public bynotifying the London Stock Exchange. If you have any questions, please contactme by telephone, at 212-698-3127, or by electronic mail atkerri.falco@asbai.com. Sincerely, Kerri Falco Compliance Analyst This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Jun 202611:18 amRNSChange in Major Shareholding
18th Jun 20267:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
8th Jun 20261:24 pmRNSDirector/PDMR Shareholding
1st Jun 202610:28 amRNSChange in Major Shareholding
29th May 20262:24 pmRNSUpdate on Directorships held by Company Directors
27th May 20263:30 pmRNSDirector/PDMR Shareholding
26th May 20265:24 pmRNSDirector/PDMR Shareholding
19th May 20269:16 amRNSChange in Major Shareholding
14th May 20262:47 pmRNSExternal Directorships held by Company Directors
14th May 202610:39 amRNSDirector/PDMR Shareholding
13th May 20264:12 pmRNSResult of AGM
13th May 20267:00 amRNSTrading Update
8th May 20263:42 pmRNSChange in Major Shareholding
7th May 20269:03 amRNSDirector/PDMR Shareholding
8th Apr 20262:22 pmRNSDirector/PDMR Shareholding
8th Apr 20269:30 amRNSAnnual Report and Accounts 2025 and Notice of AGM
18th Mar 20264:53 pmRNSDirector/PDMR Shareholding
11th Mar 20261:53 pmRNSTotal Voting Rights
10th Mar 20265:01 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS2025 Full Year Results
10th Mar 20267:00 amRNS2025 Full Year Results
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
10th Feb 20269:30 amRNSChange in Director Details
6th Feb 20263:47 pmRNSDirector/PDMR Shareholding
2nd Feb 20261:50 pmRNSChange in Director Details
30th Jan 20262:19 pmRNSHolding(s) in Company
6th Jan 20263:10 pmRNSDirector/PDMR Shareholding
18th Dec 20252:12 pmRNSCorrection: Block Listing Application
18th Dec 20252:12 pmRNSCorrection: Block Listing Application
18th Dec 202510:34 amRNSBlocklisting Application
9th Dec 20252:35 pmRNSDirector/PDMR Shareholding
18th Nov 20259:40 amRNSDirector/PDMR Shareholding
13th Nov 20257:00 amRNSTrading Update
7th Nov 20251:56 pmRNSDirector/PDMR Shareholding
5th Nov 20258:39 amRNSHolding(s) in Company
22nd Oct 20257:00 amRNSBoard Appointment
7th Oct 20255:08 pmRNSDirector/PDMR Shareholding
9th Sep 20257:00 amRNSDirector/PDMR Shareholding
1st Sep 20259:35 amRNSHolding(s) in Company
12th Aug 20257:00 amRNSBoard Committee Membership Update
12th Aug 20257:00 amRNS2025 Half Year Results
7th Aug 20257:00 amRNSDirector/PDMR Shareholding
24th Jul 20254:58 pmRNSDirector/PDMR Shareholding
9th Jul 20254:26 pmRNSDirector/PDMR Shareholding
13th Jun 20253:36 pmRNSDirector/PDMR Shareholding
14th May 20254:48 pmRNSResult of AGM
14th May 20257:00 amRNSTrading Update
8th May 202511:03 amRNSDirector/PDMR Shareholding
23rd Apr 20255:13 pmRNSChange in Director Details

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.